Delivery Order SPE2DB22D1017-SPE2DB25FYPRU
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $6.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This delivery order, valued at $43,045.46, represents a firm fixed-price contract with an ultimate completion date of August 29, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements in open competition. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $6,223.30. This non-competitive delivery order is scheduled for ultimate completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $6,223.32 and is structured as a firm fixed price delivery order with an ultimate completion date of August 14, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for RINVOQ ER 15 mg tablets in a quantity of 30 units, with a contract ceiling value of $6,823.63. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) valued at $12,222.99. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation, indicating the contract was competed openly among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $10,858.62. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for RINVOQ ER 15 mg tablets in a quantity of 30 units, with a ceiling value of $9,334.98. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for RINVOQ ER 15mg tablets (30-count supply), with a ceiling value of $13,367.72. This firm fixed-price delivery order, with a completion date of September 16, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for RINVOQ ER 30 mg tablets in a quantity of 30-count units, with a ceiling value of $14,757.54. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of RINVOQ ER 15 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $3,819.30, represents a competitive award with no set-aside designation and carries an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...